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TO THE EDITOR
Epidermolysis bullosa (EB) represents a
very heterogeneous group of inherited
diseases characterized by recurrent skin
blistering often induced by minor trau-
ma (Uitto and Richard, 2005). EB
simplex (EBS), the most common form
of EB, is characterized by intraepider-
mal blister formation (Fine et al., 2000).
This form of EB has been shown to
result from mutations in at least five
genes including KRT5, KRT14, PLEC1,
COL17A1, and ITGB4 coding for kera-
tin 5, keratin 14, plectin, collagen
17, and integrin b4 (Bonifas et al.,
1991; Coulombe et al., 1991; Lane
et al., 1992; Smith et al., 1996; Huber
et al., 2002; Jonkman et al., 2002;
Charlesworth et al., 2003; Pfendner
et al., 2005).
Among the many variants of EBS,
EBS with mottled pigmentation (EBS-
MP; MIM 131960) is associated with
exceptional clinical as well as genetic
features. The disease has its onset in
early childhood and manifests with
either very localized skin blistering,
resembling the Weber–Cockayne sub-
type of EB (MIM131800) (Coleman
et al., 1993), or with more extensive
bulla formation as seen in the Koebner
subtype of EBS (MIM131900) (Fischer
and Gedde-Dahl, 1979). Associated
features include palmoplantar kerato-
derma and late onset of pigmented and
hypopigmented spots, which have been
shown to fade with age (Fischer and
Gedde-Dahl, 1979). Most patients with
EBS-MP have been shown to carry a
dominant missense mutation in the V1
domain of K5 (P25L) (Uttam et al.,
1996) (Table 1). In contrast with almost
all other EBS-associated mutations de-
scribed to date, which are usually
affecting the a-helical rod domain of
KRT5 or KRT14 (Uitto and Richard,
2005), P25L involves the non-helical
head region of the KRT5 molecule. The
pathomechanisms underlying the un-
ique phenotypic manifestations of P25L
are still elusive. P25L-carrying keratin
molecules result in tonofilament clump-
ing (Irvine et al., 2001), suggesting that
the mutation affect the ability of keratin
intermediate filaments to assemble
properly. Abnormal phosphorylation
and impaired O-glycosylation have
been invoked to explain the deleterious
effects of P25L on the cell cytoskeleton
function (Irvine et al., 2001). Moreover,
the keratin head domain has been
suggested to play a role in melanosome
transport, which may underlie the
abnormal pigmentation pattern typical
of EBS-MP (Uttam et al., 1996). Of note,
KRT5 haploinsufficiency has been
shown to underlie Dowling–Degos dis-
ease characterized by hyperpigmenta-
tion but not skin blistering (Betz et al.,
2006). Recently, a mutation in the
KRT5 tail (V2) domain has been identi-
fied in a Japanese family presenting
with skin fragility and pigmentary
changes reminiscent of EBS-MP
(Horigushi et al., 2005). Two other
frameshift mutations in the V2 domain
of KRT5 have been described in earlier
reports (Gu et al., 2003; Sprecher et al.,
2003), one of which is identical to the
one reported to cause EBS-MP, but
nevertheless resulted in a phenotype
distinct from typical EBS-MP. In the
present report, we describe the case of
a young patient with clinical and
pathological features typical of EBS-
MP, who was found to carry a recurrent
missense mutation in KRT14.
The patient, an 8-year-old female
child, was born to unrelated parents of
Russian origin after an uneventful preg-
nancy. Her family history was unreveal-
ing and her two brothers and parents
were healthy. Immediately after birth, a
large number of blisters were noticed
over most parts of her body, without
mucosal involvement. Over the years,
the patient’s condition significantly im-
proved, although at the age of 8, three
to five new blisters were still develop-
ing every week. Her parents also
reported progressive thickening of her
palmoplantar skin and gradual appear-
ance during early childhood of pigmen-
tary changes mainly apparent over the
limbs and lower part of the trunk. Of
note, blisters did not usually precede
skin color changes. Finally, the child
has developed over the years a number
of pigmentary lesions, which were
excised because of suspicion of malig-
nant melanoma.
Abbreviations: EB, epidermolysis bullosa; EBS, EB simplex; EBS-MP, EBS with mottled pigmentation;
MP, mottled pigmentation
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On examination, numerous skin
erosions and a few tense blisters were
observed (Figure 1a). In addition, hypo-
pigmentary and hyperpigmentary
macules arranged in a mosaic-like
pattern were seen over the limbs (Figure
1b and c) and lower part of the trunk.
Six pigmented nevi were observed over
the trunk (Figure 1c, inset). Focal
keratoderma was evident over the
palms and soles (Figure 1d).
Histopathological examination of
skin blisters revealed basal cell vacuo-
lar degeneration and subepidermal
separation (Figure 1e). Using immuno-
histochemistry, we observed residual
keratin staining on the floor of the
blisters (Figure 1e, inset), consistent
with a diagnosis of EBS (Petronius
et al., 2003). Electron microscopy con-
firmed this diagnosis by demonstrating
intraepidermal blister formation asso-
ciated with tonofilament clumping
(Figure 1f). A skin biopsy from a
hyperpigmentary macule showed in-
creased melanin staining in basal cells
and the absence of dermal melano-
phages; no ultrastructural abnormalities
of melanin granules were observed
(not shown). Histological assessment
of a pigmentary nevus showed findings
typical of a benign compound melano-
cytic nevus (not shown).
The clinical and histopathological
findings suggested a diagnosis of EBS-
MP. Blood samples were obtained from
Table 1. Clinical and genetic features in EBS associated with MP
Reports
EB
subtype
Focal
PPK Other features Mutationa
Fischer and Gedde-Dahl
(1979)
K + Oral involvement,
nail dystrophy
P25L
Uttam et al. (1996) WC NR Oral blisters in son of proband P25L
Irvine et al. (1997) WC + None P25L
Moog et al. (1999) (A) WC  Mild nail dystrophy P25L
Moog et al. (1999) (B) K  None P25L
Irvine et al. (2001) (1) WC + None P25L
Irvine et al. (2001) (2) WC + None P25L
Hamada et al. (2004) WC + None P25L
Yasukawa et al. (2004) WC + None P25L
Hamada et al. (2005) K NR None P25L
Horigushi et al. (2005) K NR Small toenails 1649delG
Present study DM + None M119T
DM=Dowling–Meara type of EBS; K=Koebner type of EBS; MP=mottled pigmentation; NR=not
reported; PPK=palmoplantar keratoderma; WC=Weber–Cockayne type of EBS.
aAll mutations in KRT5, except for M119T in KRT14.
C C A N G C A
M119T/WT
C C A T G C A
WT/WT
a
e f g
b c d
Figure 1. Clinical characterization and mutation analysis in a patient with EBS associated with mottled pigmentation. (a) Hemorrhagic blisters are seen over
the right knee; (b) mosaic-like distribution of pigmented macules is evident over the left forearm; (c) higher magnification of the forearm skin shows typical
polygonal hypopigmented and hyperpigmented macules, easily distinguishable from pigmented nevi found over the trunk (inset); (d) focal plantar keratoderma is
observed over the left foot; (e) histological examination reveals basal cell vacuolar degeneration and suprabasal vesicle formation (hematoxylin and eosin,
bar¼ 40 mm). Another skin section stained with anti-pankeratin antibody demonstrates immunoreactive remaining keratinocyte materials over the blister base
(inset; immunoperoxidase, bar¼ 15 mm); (f) electron microscopy reveals severe tonofilament clumping in basal keratinocytes (bar¼ 2.4mm); and (g) direct
sequencing reveals in the proband an homozygous T-C transition at position 356 of the KRT14 cDNA sequence (upper panel), predicted to result in the
substitution of a threonine for a methionine residue at position 119 of the amino-acid sequence of KRT14 (M119T). The wild-type sequence is given for
comparison (lower panel).
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the patient and other family members
for genetic analysis. We obtained writ-
ten and informed consent of all partici-
pants or their legal guardian according
to a protocol reviewed and approved by
the local Helsinki Committee and by
the Committee for Genetic Studies of
the Israeli Ministry of Health. Genomic
DNA was extracted according to stan-
dard protocols. We initially searched
for the P25L mutation known to be
associated with EBS-MP, but failed to
identify any pathological change in the
entire coding sequence of KRT5. A
number of homozygous polymorphisms
were noticed, including synonymous
(c.A240T/p.G80G; c.C594T/p.T198T)
and non-synonymous (c.A237T/p.R79S;
c.C591A/p.D197E; c.A1159C/p.T387S)
sequence alterations. All exons and
exon–intron boundaries of the KRT14
gene were therefore subsequently
PCR amplified as described previously
(Ciubotaru et al., 2003). After gel
purification, the resulting amplicons
were directly sequenced. Mutation
analysis revealed in the patient the
presence of a heterozygous T4C
transition at position 356 of the
KRT14 cDNA sequence (starting from
ATG). Other sequence alterations
found included homozygous c.A131G/
p.N44S and heterozygous c.T189C/
p.Y63Y, c.T193C/p.L65L, c.T369C/
p.N123N, and c.G280A/p.T94A. The
T356C mutation was not found in the
patient’s father, mother, and a healthy
sibling. This mutation is predicted to
result in the substitution of a threonine
for a methionine residue at position 119
of the amino-acid sequence of KRT14
(M119T). This mutation affects a highly
conserved residue playing an important
role during keratin intermediate fila-
ment formation and has been reported
in the past in families affected with
various forms of EBS (Shemanko et al.,
1998; Cummins et al., 2001). Of note,
palmoplantar keratoderma was signifi-
cantly less severe in the present case as
compared with previous reports of
patients carrying the same mutations
(Shemanko et al., 1998; Cummins
et al., 2001), once again suggesting
the existence of modifying traits in EBS.
In summary, we have described a
young patient affected with EBS asso-
ciated with MP, palmoplantar kerato-
derma, and EB nevi. Although palmo-
plantar keratoderma and EB nevi have
been described in a wide range of
EBS and EB subtypes, respectively
(McLean, 2003; Lanschuetzer et al.,
2005), MP is generally considered as a
distinctive feature associated with a
specific genetic alteration, P25L. The
patient described in the present report
displayed all major clinical features
reported in EBS-MP, including skin
blistering, palmoplantar keratoderma,
and MP (Table 1). Although no striking
pigmentary abnormalities were ob-
served in a skin biopsy obtained from
a hyperpigmented spot, normal findings
have similarly been reported in other
cases of EBS-MP (Fischer and Gedde-
Dahl, 1979; Coleman et al., 1993).
Thus, the present report as well as a
previous study (Horigushi et al., 2005)
shows that mutations distinct from P25L
can underlie EBS-MP, suggesting the
involvement of additional keratin do-
mains in the regulation of pigment
distribution. Although keratin defects
have been linked to abnormal pigment
distribution in the skin in both humans
(Uttam et al., 1996; Betz et al., 2006)
and animal models (Fitch et al., 2003),
the fact that MP was not described in
previous reports of heterozygous car-
riers of M119T (Shemanko et al., 1998;
Cummins et al., 2001) indicates that
this genetic defect is not sufficient in
itself to cause epidermal pigmentary
changes. Interestingly, a number of
genodermatoses have been shown to
combine diverse degrees of MP, skin
blistering, and palmoplantar keratoder-
ma such as the Naegeli–Franceschetti–-
Jadassohn syndrome (MIM161000; Itin
et al., 1993), dermatopathia pigmentosa
reticularis (MIM125595; Heimer et al.,
1992), dyskeratosis congenita
(MIM305000, MIM127550; Mason
et al., 2005), and Mendes Da Costa
syndrome (MIM302000; Hassing and
Doeglas, 1980), pointing to the exis-
tence of a wide range of genetic
determinants of this cutaneous trait.
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TO THE EDITOR
CDKN2A (OMIM 600160) is the major
melanoma susceptibility gene identified
to date, which predisposes to familial
melanoma and multiple primary mela-
noma (MPM). Germline CDKN2A mu-
tations have been detected with a
frequency varying from 5 to 46% in
melanoma families from different coun-
tries (Holland et al., 1995; Walker
et al., 1995; FitzGerald et al., 1996;
Soufir et al., 1998). Different ethnic and
environmental factors might account
for such different percentages. The
majority of CDKN2A germline muta-
tions has been found in exons 1a and 2
of the CDKN2A gene affecting predomi-
nantly the p16INK4A transcript (Stahl et al.,
2004). However, a specific role for the
p14ARF transcript has been suggested by
the identification of a germline deletion
of the CDKN2A gene involving exon 1b
(Hewitt et al., 2002) and of five different
germline mutations at the p14ARF exon
1b splice donor site in familial melanoma
kindreds (Harland et al., 2005).
Three polymorphisms have been
detected in the CDKN2A gene includ-
ing one coding variant (c.442G4A)
localized in exon 2 and two noncoding
variants (c.500C4G and c.540C4T)
localized in the 30 untranslated region.
The c.442G4A variant converts an
alanine (GCG) to a threonine (ACG)
residue at codon 148 (A148T), located
in the fourth ankyrin repeat domain,
and has no recognized effect on
p16INK4A function (Ranade et al.,
1995; Lilischkis et al., 1996). The
A148T allele frequency has been re-
ported to vary from 1.5% in the CEPH
population (Hussussian et al., 1994) to
2% in the Utah population (Kamb et al.,
1994), and it has been recently sug-
gested to be a low penetrance mela-
noma susceptibility allele in a popula-
tion from Poland (Debniak et al., 2005).Abbreviations: CI, confidence interval; MPM, multiple primary melanoma; OR, odds ratio
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